ロード中...
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
BACKGROUND: The co-receptor lymphocyte-activation gene-3 (LAG3, LAG-3, CD223) is a potential target for immune checkpoint inhibition immunotherapies. However, little is known about the biological and clinical significance of LAG3 DNA methylation in melanoma and its microenvironment. METHODS: We eval...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475111/ https://ncbi.nlm.nih.gov/pubmed/32861198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102962 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|